Medistim ASA (MEDI) - Total Liabilities
Based on the latest financial reports, Medistim ASA (MEDI) has total liabilities worth Nkr151.23 Million NOK (≈ $15.91 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore MEDI operating cash flow to assess how effectively this company generates cash.
Medistim ASA - Total Liabilities Trend (2004–2024)
This chart illustrates how Medistim ASA's total liabilities have evolved over time, based on quarterly financial data. Check Medistim ASA liquidity resilience to evaluate the company's liquid asset resilience ratio.
Medistim ASA Competitors by Total Liabilities
The table below lists competitors of Medistim ASA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Youlchon Chem
KO:008730
|
Korea | ₩371.88 Billion |
|
Smcp SAS
PA:SMCP
|
France | €978.00 Million |
|
Wave Cyber Shanghai Co Ltd
SHG:688718
|
China | CN¥141.72 Million |
|
Kyverna Therapeutics, Inc. Common Stock
NASDAQ:KYTX
|
USA | $35.21 Million |
|
Laxmi Organic Industries Limited
NSE:LXCHEM
|
India | Rs12.67 Billion |
|
Vishnu Chemicals Limited
NSE:VISHNU
|
India | Rs8.27 Billion |
|
Chaun-Choung Technology Corp
TW:6230
|
Taiwan | NT$4.51 Billion |
|
Sofwave Medical Ltd
TA:SOFW
|
Israel | ILA18.95 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down Medistim ASA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Medistim ASA (MEDI) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medistim ASA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medistim ASA (2004–2024)
The table below shows the annual total liabilities of Medistim ASA from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Nkr138.36 Million ≈ $14.56 Million |
+28.37% |
| 2023-12-31 | Nkr107.78 Million ≈ $11.34 Million |
-6.25% |
| 2022-12-31 | Nkr114.97 Million ≈ $12.10 Million |
+18.29% |
| 2021-12-31 | Nkr97.19 Million ≈ $10.23 Million |
+9.24% |
| 2020-12-31 | Nkr88.97 Million ≈ $9.36 Million |
-10.35% |
| 2019-12-31 | Nkr99.25 Million ≈ $10.44 Million |
+57.84% |
| 2018-12-31 | Nkr62.88 Million ≈ $6.62 Million |
-7.64% |
| 2017-12-31 | Nkr68.08 Million ≈ $7.16 Million |
+35.23% |
| 2016-12-31 | Nkr50.34 Million ≈ $5.30 Million |
-19.15% |
| 2015-12-31 | Nkr62.27 Million ≈ $6.55 Million |
-3.29% |
| 2014-12-31 | Nkr64.39 Million ≈ $6.78 Million |
+37.72% |
| 2013-12-31 | Nkr46.76 Million ≈ $4.92 Million |
+27.41% |
| 2012-12-31 | Nkr36.70 Million ≈ $3.86 Million |
-14.14% |
| 2011-12-31 | Nkr42.74 Million ≈ $4.50 Million |
+12.15% |
| 2010-12-31 | Nkr38.11 Million ≈ $4.01 Million |
-3.11% |
| 2009-12-31 | Nkr39.33 Million ≈ $4.14 Million |
-21.21% |
| 2008-12-31 | Nkr49.92 Million ≈ $5.25 Million |
+42.82% |
| 2007-12-31 | Nkr34.96 Million ≈ $3.68 Million |
-22.47% |
| 2006-12-31 | Nkr45.09 Million ≈ $4.74 Million |
+156.44% |
| 2005-12-31 | Nkr17.58 Million ≈ $1.85 Million |
+40.95% |
| 2004-12-31 | Nkr12.47 Million ≈ $1.31 Million |
-- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more